Windlas Biotech unveils IPO

The initial public offering (IPO) of Windlas Biotech Ltd., a maker of pharma formulations, will open on August 4. The price band has been fixed at ₹448 to ₹460 per equity share of the face value of ₹5. Bids can be made for a minimum of 30 shares and in multiples of 30 shares thereafter. The IPO comprises fresh issue of up to ₹165 crore and an offer for sale of up to 5,142,067 shares by selling investors.

Our code of editorial values

This article is closed for comments.
Please Email the Editor

Printable version | Sep 26, 2021 12:37:43 PM |

Next Story